Oruka Therapeutics (ORKA) Interest & Investment Income (2010 - 2024)
Oruka Therapeutics (ORKA) posted quarterly Interest & Investment Income of $444000.0 for Q2 2024, down 9.94% year-over-year from $493000.0 in Q3 2023, and down 6.13% quarter-over-quarter from $473000.0 in Q1 2024.
Powered by 
Analysis
Oruka Therapeutics (ORKA) Interest & Investment Income (2010 - 2024) Analysis & Trends
Oruka Therapeutics' Interest & Investment Income history runs 15 years deep, the most recent figure standing at $444000.0 for Q2 2024.
- In Q2 2024, Interest & Investment Income fell 9.94% year-over-year to $444000.0; the TTM figure through Jun 2024 stood at $1.9 million (up 25.47% YoY), while the FY2023 annual figure was $2.0 million, up 189.93% from the prior year.
- Interest & Investment Income for Q2 2024 stood at $444000.0, down from $473000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $513000.0 in Q3 2023, with the low at $1000.0 in Q3 2020.
- The 5-year median for Interest & Investment Income is $48000.0 (2020), against an average of $199444.4.
- The sharpest annual moves came in 2020 and 2022: Interest & Investment Income slumped 98.0% in 2020, then soared 9250.0% in 2022.
- Oruka Therapeutics' Interest & Investment Income stood at $1000.0 in 2020, then jumped by 300.0% to $4000.0 in 2021, then jumped by 9250.0% to $374000.0 in 2022, then jumped by 33.96% to $501000.0 in 2023, then decreased by 11.38% to $444000.0 in 2024.
- Business Quant data shows ORKA's Interest & Investment Income at $444000.0 in Q2 2024, $473000.0 in Q1 2024, and $501000.0 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.26 Bn | 131.41 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 57.83 Bn | 52.69 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 39.94 Bn | 34.84 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.19 Bn | 31.88 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Oruka Therapeutics | 5.82 Bn | 4.09 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 444,000.00 |
| Mar 31, 2024 | 473,000.00 |
| Dec 31, 2023 | 501,000.00 |
| Sep 30, 2023 | 513,000.00 |
| Jun 30, 2023 | 493,000.00 |
| Mar 31, 2023 | 450,000.00 |
| Dec 31, 2022 | 374,000.00 |
| Sep 30, 2022 | 222,000.00 |
| Jun 30, 2022 | 72,000.00 |
| Mar 31, 2022 | 7,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | 4,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Jun 30, 2020 | 2,000.00 |
| Mar 31, 2020 | 24,000.00 |
| Dec 31, 2019 | 36,000.00 |
| Sep 30, 2019 | 50,000.00 |